2022 Vaccines for Adults (VFA)

Awarded Award Notice Posted

Solicitation number
75D30122D14070
Agency
CDC Office of Acquisition Services Centers for Disease Control and Prevention, Department of Health and Human Services
Awarded
to Glaxosmithkline, LLC
Set-aside
No set-aside

Opportunity facts

Contract number
75D30122D14070 Federal IDV award
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Place of performance
United States

Notice details come from SAM.gov. Updated .

About this opportunity

On June 28, 2022, the Department of Health and Human Services Centers for Disease Control and Prevention Office of Acquisition Services awarded contract 75D30122D14070 to GLAXOSMITHKLINE LLC for $161,255,900 to provide vaccines for adults under the 2022 Vaccines for Adults (VFA) opportunity. The contract was awarded without a set-aside designation and was posted for public notice on July 5, 2022.

Notice text

Awarded contract 75D30122D14070 to GLAXOSMITHKLINE LLC for 161255900.00 on 2022-06-28.

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
2022 Vaccines for Adults (VFA) Latest Award Notice
2022 Vaccines for Adults (VFA) Award Notice
2022 Vaccines for Adults (VFA) Award Notice
2022 Vaccines for Adults (VFA) This notice Award Notice
2022 Vaccines for Adults (VFA) Latest solicitation Solicitation

And 2 more award notices.

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity